Navitoclax
| Catalog Number | Pack Size | List Price* | Promo Price* | Quantity | |
|---|---|---|---|---|---|
| HY-10087-1MG | 1mg | 47,00 | 30,60 | Add | |
| HY-10087-5MG | 5 mg | 80,00 | 52,00 | Add | |
| HY-10087-10MG | 10 mg | 106,00 | 68,90 | Add | |
| HY-10087-1ML | 10mM/1mL | 113,00 | 73,50 | Add | |
| HY-10087-50MG | 50 mg | 253,00 | 164,50 | Add | |
| HY-10087-100MG | 100 mg | 346,00 | 224,90 | Add | |
| HY-10087-500MG | 500 mg | 1'077,00 | 700,10 | Add | |
| HY-10087-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Promotion runs until 31.12.2024Year-End Promotion : 35% discount on the entire MedChem Express portfolio
ABT-263
Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2 and Bcl-w, with a Ki of less than 1 nM[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer |
| Format | Solubility: DMF : ≥ 100 mg/mL;DMSO : 75 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 3 |
| Purity | 99.97% |
| Molecular Formula | C47H55ClF3N5O6S3 |
| Molecular Weight | 974.61 |
| CAS-Number | 923564-51-6 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
